Topamax Mega Study
Contents
Topamax
Topamax

Related

A
Count
A
Treatments
A
Effects
A
User Variables 3
A
Measurements 10

Tags

Topamax

Treatment Effectiveness

User reported effectiveness ratings Topamax for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Bipolar Disorder 32% 23% 5% 32% 9% 22
Cluster Headaches 20% 40% 20% 20% 0% 5
Hemicrania Continua 0% 17% 31% 44% 8% 36
Myofascial Pain Syndrome 33% 33% 0% 0% 33% 3
Neuropathy 33% 17% 0% 25% 25% 12

Below is the degree of change seen after Topamax is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Topamax Info

Property Value
Variable Name Topamax
Aggregation Method SUM
Analysis Performed At 2020-10-09
Duration of Action 21 days
Filling Value 0
Kurtosis 31.468491520365
Mean 10.47635 count
Median 0 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 34
Number of Measurements 10
Number of Measurements (including those generated by tagged, joined, or child variables) 10
Public true
Onset Delay 30 minutes
Standard Deviation 31.100569460725
Unit Count
User Variables 3
UPC 852659006663
Variable Category Treatments
Variable ID 95594
Variance 1298.1442577031